HIGHLIGHTS
- who: Carsten Gründker and Günter Emons from the Department of Gynecology and Obstetrics, University Medicine Göttingen, Göttingen, Germany have published the research: Role of Gonadotropin-Releasing Hormone (GnRH) in Ovarian Cancer, in the Journal: Cells 2021, 10, 437. of /2021/
- what: Unfortunately, this study showed no benefits of suppression of gonadotropins by treatment with GnRH agonist triptorelin in progression-free and overall survival .
- how: Unfortunately zoptarelin doxorubicin was discontinued and no phase III trial was conducted in ovarian cancer.
SUMMARY
The authors shed light on . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.